Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wolter

Showing results (161-170 of 259) with videos related to

Pageof 26
Sort By:
Cancer|January 15, 1990
Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trialD C Tormey, R Gray, K Gilchrist, et al.
Cancer|September 1, 1979
A randomized comparison of two dosage schedules of methyl CCNU: three-week versus six-week treatmentsS G Taylor, W D DeWys, C P Perlia, et al.
Ultramicroscopy|January 23, 2016
Mechanical characterization of porous nano-thin films by use of atomic force acoustic microscopyM Kopycinska-Müller, A Clausner, K-B Yeap, et al.
Journal of Pediatric Surgery|January 18, 2006
Study of the factors associated with recurrence in children with sacrococcygeal teratomaAntoine De Backer, Gerard C Madern, Friederike G A J Hakvoort-Cammel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Role of P53 and MDM2 in treatment response of human germ cell tumorsAnne-Marie F Kersemaekers, Frank Mayer, Michel Molier, et al.
BMC Medical Genetics|November 20, 2012
SRY mutation analysis by next generation (deep) sequencing in a cohort of chromosomal Disorders of Sex Development (DSD) patients with a mosaic karyotypeRemko Hersmus, Hans Stoop, Erin Turbitt, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 19, 2002
VASA is a specific marker for both normal and malignant human germ cellsAnne-Marie Zeeman, Hans Stoop, Marjan Boter, et al.
Clinical Endocrinology|March 12, 2024
Response to letter to the editor: 'Gonadal tumour screening in XY gonadal dysgenesis'Sabine E Hannema, Katja P Wolffenbuttel, Yolande van Bever, et al.
Integrated Healthcare Report|July 1, 1999
Specialist collaboration strategies--roundtable discussionJ L Bradley, J T Allison, M E Waters, et al.
Breast Cancer Research and Treatment|January 1, 1983
Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapyB Fisher, C K Redmond, D L Wickerham, et al.
Pageof 26

Showing results (161-170 of 259) with videos related to

Sort By:
Pageof 26
Cancer|January 15, 1990
Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trialD C Tormey, R Gray, K Gilchrist, et al.
Cancer|September 1, 1979
A randomized comparison of two dosage schedules of methyl CCNU: three-week versus six-week treatmentsS G Taylor, W D DeWys, C P Perlia, et al.
Ultramicroscopy|January 23, 2016
Mechanical characterization of porous nano-thin films by use of atomic force acoustic microscopyM Kopycinska-Müller, A Clausner, K-B Yeap, et al.
Journal of Pediatric Surgery|January 18, 2006
Study of the factors associated with recurrence in children with sacrococcygeal teratomaAntoine De Backer, Gerard C Madern, Friederike G A J Hakvoort-Cammel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Role of P53 and MDM2 in treatment response of human germ cell tumorsAnne-Marie F Kersemaekers, Frank Mayer, Michel Molier, et al.
BMC Medical Genetics|November 20, 2012
SRY mutation analysis by next generation (deep) sequencing in a cohort of chromosomal Disorders of Sex Development (DSD) patients with a mosaic karyotypeRemko Hersmus, Hans Stoop, Erin Turbitt, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 19, 2002
VASA is a specific marker for both normal and malignant human germ cellsAnne-Marie Zeeman, Hans Stoop, Marjan Boter, et al.
Clinical Endocrinology|March 12, 2024
Response to letter to the editor: 'Gonadal tumour screening in XY gonadal dysgenesis'Sabine E Hannema, Katja P Wolffenbuttel, Yolande van Bever, et al.
Integrated Healthcare Report|July 1, 1999
Specialist collaboration strategies--roundtable discussionJ L Bradley, J T Allison, M E Waters, et al.
Breast Cancer Research and Treatment|January 1, 1983
Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapyB Fisher, C K Redmond, D L Wickerham, et al.
Pageof 26